Publications

Export 3 results:
Sort by: [ Author (Asc)] Title Type Year
Filters: Author is Brennan, Danielle M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Berger PB, Bhatt DL, Fuster V, Steg GP, Fox KA, Shao M, et al. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: Results from the (CHARISMA) trial. Circulation. 2010;121(23):2575-83. Abstract
H
Hankey GJ, Hacke W, Easton DJ, Johnston CS, Mas J-, Brennan DM, et al. Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial. Stroke. 2010;41(8):1679-83. Abstract
W
Weber M, Bhatt DL, Brennan DM, Hankey GJ, Steinhubl SR, Johnston CS, et al. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial. Heart. 2011;97(8):626-31. Abstract